Manifold is an AI platform purpose-built for the life sciences industry, addressing a critical challenge: despite major advances in biology, data generation, and AI, progress in drug development has slowed due to fragmented data, brittle infrastructure, and workflows not designed for secure collaboration or AI-driven analysis.
The Problem We Solve:
Life sciences is a $2 trillion industry where productivity directly impacts patient outcomes. Scientists and researchers face critical bottlenecks—their work is blocked by scattered data across multiple systems, unreliable technical infrastructure, and legacy processes that can't support modern AI analysis or secure team collaboration. These inefficiencies delay the discovery and development of life-changing medicines.
Our Solution:
We've built a vertical AI platform specifically for life sciences organizations. Rather than trying to adapt generic AI tools, we've created domain-specific technology that understands the unique requirements of biotech, pharma, and academic research. Our platform combines three core capabilities:
- Agentic AI - Autonomous AI systems that can execute complex scientific workflows
- Deep life sciences context - Built-in understanding of biology, clinical data, and research processes
- Enterprise-grade governance - Security and compliance features required for sensitive health data
Our Impact:
By integrating these capabilities into one platform, we help research teams move from scientific question to insight faster. This acceleration means potentially life-saving treatments can reach patients sooner.
Our Market Position:
We believe vertical AI—industry-specific AI platforms—represents the next major platform shift in technology. Our thesis is that industries like life sciences require specialized solutions rather than general-purpose AI tools.
Our Scale & Traction:
Our platform serves leading organizations including Foundation Medicine, the Broad Institute, and the University of Virginia, supporting tens of thousands of users across hundreds of organizations globally. Backed by prominent investors (Reach Capital, TQ Ventures, Calibrate Ventures, SilverArc Capital, and Industry Ventures), we've raised $40M to date.
In essence, we're building the operating system for AI-powered life sciences research—helping scientists work smarter and faster to bring new medicines to patients who need them.
